About the Authors
- Fadi Towfic
-
Contributed equally to this work with: Fadi Towfic, Jason M. Funt, Kevin D. Fowler
Affiliation Immuneering Corporation, Cambridge, Massachusetts, United States of America
- Jason M. Funt
-
Contributed equally to this work with: Fadi Towfic, Jason M. Funt, Kevin D. Fowler
Affiliation Immuneering Corporation, Cambridge, Massachusetts, United States of America
- Kevin D. Fowler
-
Contributed equally to this work with: Fadi Towfic, Jason M. Funt, Kevin D. Fowler
Affiliation Immuneering Corporation, Cambridge, Massachusetts, United States of America
- Shlomo Bakshi
-
Affiliation Teva Pharmaceutical Industries, Petach Tikva, Israel
- Eran Blaugrund
-
Affiliation Teva Pharmaceutical Industries, Petach Tikva, Israel
- Maxim N. Artyomov
-
Affiliation Immuneering Corporation, Cambridge, Massachusetts, United States of America
- Michael R. Hayden
-
Affiliation Teva Pharmaceutical Industries, Petach Tikva, Israel
- David Ladkani
-
¶These authors also contributed equally to this work.
Affiliation Teva Pharmaceutical Industries, Petach Tikva, Israel
- Rivka Schwartz
-
¶These authors also contributed equally to this work.
Affiliation Teva Pharmaceutical Industries, Petach Tikva, Israel
- Benjamin Zeskind
-
* E-mail: bzeskind@immuneering.com
¶These authors also contributed equally to this work.
Affiliation Immuneering Corporation, Cambridge, Massachusetts, United States of America
Competing Interests
The authors have read the journal's policy and have the following conflicts: all authors are employees, advisors, and/or stockholders of Immuneering or Teva. This does not alter adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SB EB MRH DL RS. Performed the experiments: SB RS. Analyzed the data: FT JMF KDF SB EB MNA MRH DL RS BZ. Contributed reagents/materials/analysis tools: FT JMF KDF MNA BZ. Wrote the paper: FT JMF KDF SB EB MNA MRH DL RS BZ.